Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model.
Eikan Mishima, S. Fukuda, Yoshitomi Kanemitsu, D. Saigusa +16 more
2018AJP - Renal Physiology94 citations
Semantic Scholar

